Topluluğumuzun bir parçası olmanızı çok isteriz. Discord'umuza katılın bizimle ve diğer üyelerle bağlantı kurmak için!

Ticker
LH.MX

Price
5245.61
Stock movement up
+- (%)
Company name
Labcorp Holdings Inc.
Exchange
(MX
,
Currency
MXN
)
Sector
Healthcare >
Diagnostics & Research
Piyasa değeri
421.46B
Ent değeri
-
Fiyat/Satış
-
Fiyat/Defter
-
DIV kazancı
-
DIV büyümesi
-
Büyüme yılları
-
FCF ödemesi
-
Trailing P/E
-
İleri P/E
-
PEG
-
EPS büyümesi
-
1 yıllık getiri
27.27%
3 yıllık getiri
5.01%
5 yıllık getiri
6.14%
10 yıllık getiri
-
Son güncelleme: 2025-09-17

TEMETTÜLER

LH.MX temettü ödemiyor veya veri alınmadı

DEĞERLEME

Değerleme Oranları

Loading...
Değerleme Oranları verileri
Trailing P/E-
OCF Fiyatı-
FCF Fiyatı-
EBITDA Fiyatı-
EBITDA EV-

Değerleme (Satış/Defter Değeri)

Loading...
Değerleme (Satış/Defter Değeri) verileri
Satış Fiyatı-
Kitap Fiyatı-
Satışa EV-

MALİ HUSUSLAR

HİSSE SENEDİ BİLGİSİ

Stok çizelgesi

Loading...
Hisse senedi verisi
5071.76
Günlük yüksek5071.76
Günlük düşük5071.76
Günlük Hacim0K
Tüm zamanların en yükseği5559.07
1y analist tahmini-
Beta0.83
EPS (TTM)-
Hisse başına temettü0.00
Eski temettü tarihi28 Aug 2025
Bir sonraki kazanç tarihi5 Feb 2026

Aşağı yönlü potansiyel

Loading...
Aşağı yönlü potansiyel veriler
LH.MXS&P500
Tüm zamanların en yüksek seviyesinden geçerli fiyat düşüşü-5.64%-0.20%
En yüksek fiyat düşüşü-39.20%-19.00%
En yüksek düşüş tarihi4 Jan 20198 Apr 2025
Yüksekten ort düşme-17.86%-2.76%
Yeni yükseğe çıkmak için ortalama süre6 days5 days
Yeni yükseğe çıkmak için maksimum süre924 days89 days
ŞİRKET AYRINTILARI
LH.MX (Labcorp Holdings Inc.) company logo
Piyasa değeri
421.46B
Piyasa değeri kategorisi
Large-cap
Açıklama
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governments, physician, large provider organizations, other healthcare providers, hospitals and health systems, patients and consumers, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
Çalışanlar
70000
Yatırımcı ilişkileri
-
SEC dosyaları
CEO
Ülke
Mexico
Şehir
Stok türü
-
CCC durumu
-
Temettü Sıklığı
-
ETKİNLİKLER VE SUNUMLAR
EtkinliklerSunumlar
Loading...
İŞİ ANLAYIN
Loading...
ŞİRKET HABERLERİ
DuyurularBasın bültenleri
OPKO Health recently reported third-quarter earnings with revenue of US$151.67 million and net income of US$21.63 million, surpassing analyst expectations, and announced a collaboration with Regeneron...
31 Ekim 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
31 Ekim 2025
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...
31 Ekim 2025
Labcorp Holdings Inc (LH) reports a robust 9% revenue increase and a 19% rise in adjusted EPS, while navigating challenges in early development and currency impacts.
30 Ekim 2025
Labcorp Holdings (LH) posted a net profit margin of 6.2% for the period, up from 3.4% a year ago, as earnings surged 96.4% year-over-year. This is well above the company's five-year average despite a ...
30 Ekim 2025
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 8.6% year on year to $3.56 billion. Its non-GAAP profit of $4.18 per share ...
29 Ekim 2025
Shares of healthcare diagnostics company Labcorp Holdings (NYSE:LH) fell 3.8% in the morning session after the company's third-quarter results, while beating headline estimates, revealed a miss on a k...
28 Ekim 2025
Labcorp's Q3 earnings beat forecasts and margins improve, but a trimmed 2025 sales outlook sends shares down.
28 Ekim 2025
Margin for the quarter improved 100 basis points, driven by Diagnostics. Adjusted EPS grew 19%, and we generated strong free cash flow of $281 million. Moving to our business segments, Diagnostics r...
28 Ekim 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
28 Ekim 2025
Sonraki sayfa